Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin

Author:

Soltani Abbas1ORCID,Pakravan Parvaneh1ORCID

Affiliation:

1. Department of Chemistry, Zanjan Branch, Islamic Azad University, Zanjan, Iran.

Abstract

Purpose: In the present study, we investigated the magnetic solid lipid nanoparticles for targeted delivery of Doxorubicin into breast cancer cells. Methods: The synthesis of iron oxide nanoparticles was carried out by co-precipitation of a ferrous and ferric aqueous solution with the addition of a base; moreover, during precipitation process, the magnetite nanoparticles should be coated with Stearic acid and Tripalmitin. An emulsification dispersion-ultrasonic method was employed to prepare doxorubicin loaded magnetic solid lipid nanoparticles. Fourier transforms infrared spectroscopy, vibrating sample magnetometer, and photon correlation spectroscopy were used to characterize the subsequently prepared nanoparticles. In addition, the antitumor efficacy of particles was evaluated on MCF-7 cancer cell lines. Results: The findings showed that entrapment efficiency values for solid lipid and magnetic solid lipid nanoparticles were 87±4.5% and 53.7±3.5%, respectively. PCS investigations showed that particle size increased with magnetic loading in the prepared NPs. In vitro drug release of Doxorubicin-loaded SLN and Doxorubicin-loaded mSLN in phosphate buffer saline (pH = 7.4) showed that the amount of drug released approached 60% and 80%, respectively after 96 h of incubation. The electrostatic interactions between magnetite and drug had little effect on the release characteristics of the drug. The higher toxicity of Doxorubicin as nanoparticles compared to free drug was inferred from in vitro cytotoxicity. Conclusion: Doxorubicin encapsulated magnetic SLNs can act as a suitable and promising candidate for controlled and targeted therapy for cancer.

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3